DB
Debopriya Bhadra
About Debopriya Bhadra
Data last updated:
Debopriya Bhadra is a Director at Revanex Pharmaceuticals Private Limited (since 2024) and Director at Alpharen Lifesciences Private Limited (since 2026). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Revanex Pharmaceuticals Private Limited at ₹1.25 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revanex Pharmaceuticals Private Limited U24290WB2022PTC257023 | Director | 25 Aug 2024 | 2022 | ₹1.25 Cr (FY 2025) | Active |
| Alpharen Lifesciences Private Limited U46497WB2026PTC286946 | Director | 09 Feb 2026 | 2026 | Active |
Board colleagues of Debopriya Bhadra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babita Kumari | 09755265 | Revanex Pharmaceuticals Private Limited | Director |
| Kumari Kavita | 09755266 | Revanex Pharmaceuticals Private Limited | Director |
| Mita Mukhertee | 08450834 | Revanex Pharmaceuticals Private Limited , Alpharen Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Debopriya Bhadra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Debopriya Bhadra
Debopriya Bhadra currently holds 2 directorships: Revanex Pharmaceuticals Private Limited (Director, since 25 Aug 2024, revenue ₹1.25 Cr (FY 2025)); Alpharen Lifesciences Private Limited (Director, since 09 Feb 2026).
Debopriya Bhadra was first appointed on 25 Aug 2024 as Director at Revanex Pharmaceuticals Private Limited. The most recent appointment on record is 09 Feb 2026 at Alpharen Lifesciences Private Limited.
The current boards of Debopriya Bhadra's companies include Babita Kumari (Revanex Pharmaceuticals Private Limited), Kumari Kavita (Revanex Pharmaceuticals Private Limited), Mita Mukhertee (Revanex Pharmaceuticals Private Limited).